Srinath Nephrocare Private Limited
About Srinath Nephrocare Private Limited
Data last updated:
Srinath Nephrocare Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Fresenius Medical Care India Private Limited. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the renal care and dialysis clinics segment of the healthcare sector. It was incorporated on 30 November 2012.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2012PTC245524. Its GSTIN is 03AASCS3557R3ZF (Punjab). The company holds 4 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.8 Cr. It is led by directors including Rajeev Kumar Bhatia and Ajay Marwaha.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at S – 21 Second Floor Star City District Centre Mayur Place Mayur Vihar Phase – 1, New Delhi, Delhi, India – 110091.
As per the financials filed for FY 2017, the company reported a revenue of ₹2.98 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net loss of ₹7.79 Lakh (net margin -2.6%) and EBITDA of ₹20.6 Lakh (EBITDA margin 6.9%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressS – 21 Second Floor Star City District Centre Mayur Place Mayur Vihar Phase – 1, New Delhi, Delhi, India – 110091
- IndustryHealthcare, Renal Care & Dialysis Clinics
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Srinath Nephrocare Private Limited FY 2024 filings available
Srinath Nephrocare Private Limited reported revenue of ₹2.98 Cr (up 16% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR) of Srinath Nephrocare Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 30% over three years, including 16% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Srinath Nephrocare Private Limited
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹2.98 Cr | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹20.6 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹7.79 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Srinath Nephrocare Private Limited
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 6.9% | •••• | •••• |
| Net Profit Margin | -2.6% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Srinath Nephrocare are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Srinath Nephrocare Private Limited
Srinath Nephrocare Private Limited is audited by Walker Chandiok & Co LLP for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Walker Chandiok & Co LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Srinath Nephrocare Private Limited
Srinath Nephrocare has 6 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Kumar Bhatia | Director | 30 Nov 2012 | 13 Years 10 Months | As last reported |
| Ajay Marwaha | Director | 30 Nov 2012 | 13 Years 10 Months | As last reported |
| Gyaneshwar Sahai Also directs: Associated Procons LLP, Algoquant Fintech Limited, Integrated Capital Services Limited and 1 more | Irp/Rp/Liquidator | 03 Jan 2025 | 1 Years 9 Months | As last reported |
| Anand Goyal | Director | 11 May 2023 | 3 Years 4 Months | As last reported |
| Bhaskar Sunil Guha | Director | 11 May 2023 | 3 Years 4 Months | As last reported |
| Rekha Alex Daniel | Director | 11 May 2023 | 3 Years 4 Months | As last reported |
Ownership and Shareholding of Srinath Nephrocare Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Srinath Nephrocare Private Limited
Srinath Nephrocare Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Srinath Nephrocare Private Limited
Employment history and EPFO contributions of people linked to Srinath Nephrocare.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Srinath Nephrocare Private Limited
Srinath Nephrocare Private Limited has 16 board changes on record since 2012: 6 appointments and 10 cessations. The latest: Rekha Alex Daniel ceased to be Director on 31 Mar 2025.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Srinath Nephrocare Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Srinath Nephrocare Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Srinath Nephrocare Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Srinath Nephrocare Private Limited
Srinath Nephrocare has 4 GST registrations: 1 active and 3 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AASCS3557R3ZF | Punjab | Active | 01 Feb 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Srinath Nephrocare Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srinath Nephrocare Private Limited
Srinath Nephrocare is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Srinath Nephrocare is a company under liquidation, formerly operating as a private limited company based in New Delhi, Delhi, India. The company works in renal care and dialysis clinics, within the healthcare industry. It was incorporated on 30 November 2012 and is registered under CIN U85100DL2012PTC245524. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Srinath Nephrocare reported revenue of ₹2.98 Cr for FY 2017 (up 16% YoY).
Srinath Nephrocare has 6 current directors:
- Rajeev Kumar Bhatia - Director
- Ajay Marwaha - Director
- Anand Goyal - Director
- Bhaskar Sunil Guha - Director
- Rekha Alex Daniel - Director
- Gyaneshwar Sahai - Irp/Rp/Liquidator
Srinath Nephrocare reported a net loss of ₹7.79 Lakh (net margin -2.6%) and EBITDA of ₹20.6 Lakh (EBITDA margin 6.9%) for FY 2017, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Srinath Nephrocare is 30% over three years. In the latest year (FY 2017) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Srinath Nephrocare is U85100DL2012PTC245524. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Srinath Nephrocare was incorporated on 30 November 2012. It is registered with the Registrar of Companies, Delhi.
Rekha Alex Daniel ceased to be Director on 31 Mar 2025. Gyaneshwar Sahai was appointed as Irp/Rp/Liquidator on 03 Jan 2025. Pankaj Kumar ceased to be Nominee Director on 18 Sep 2023. Srinath Nephrocare has 16 board changes on record in total.
The registered office of Srinath Nephrocare is at S – 21 Second Floor Star City District Centre Mayur Place Mayur Vihar Phase – 1, New Delhi, Delhi, India – 110091.